Filing Details
- Accession Number:
- 0001014108-15-000110
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-07 10:42:15
- Reporting Period:
- 2015-04-06
- Filing Date:
- 2015-04-07
- Accepted Time:
- 2015-04-07 10:42:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1084597 | Xzeres Corp. | XPWR | Engines & Turbines (3510) | 742329327 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1598555 | Paul Debruce | 411 Nichols Road, Suite 217 Kansas City MO 64112 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $.001 Per Share | Acquisiton | 2015-04-06 | 3,967,000 | $0.15 | 15,219,672 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Warrants (right to buy) | $0.23 | 2013-07-31 | 2017-07-31 | 976,658 | 976,658 | Direct |
Common Stock | Warrants (right to buy) | $0.25 | 2013-10-01 | 2017-10-01 | 687,047 | 687,047 | Direct |
Common Stock | Warrants (right to buy) | $0.31 | 2013-12-16 | 2016-12-16 | 2,794,256 | 2,794,256 | Direct |
Common Stock | Warrants (right to buy) | $0.30 | 2014-04-23 | 2018-04-23 | 1,144,984 | 1,144,984 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2017-07-31 | 976,658 | 976,658 | Direct |
2017-10-01 | 687,047 | 687,047 | Direct |
2016-12-16 | 2,794,256 | 2,794,256 | Direct |
2018-04-23 | 1,144,984 | 1,144,984 | Direct |
Footnotes
- The number of shares to which these warrants relate, as well as their respective exercise prices, are subject to antidilution adjustment provisions.
- This warrant is exercisable for such number of shares as equals 1.03459% of the fully diluted outstanding shares of Common Stock upon payment of an aggregate exercise price of $228,951, and previously was reported as relating to 829,246 shares. After giving effect to the warrant's antidilution provisions, as of April 3, 2015, the warrant is exercisable for a total of 976,658 shares of Common Stock upon payment of an aggregate exercise price of $228,951 ($0.2344 per share), subject to further adjustment under the warrant's antidilution provisions.
- This warrant is exercisable for such number of shares as equals 0.7278% of the fully diluted outstanding shares of Common Stock upon payment of an aggregate exercise price of $174,417, and previously was reported as relating to 583,347 shares. After giving effect to the warrant's antidilution provisions, as of April 3, 2015, the warrant is exercisable for a total of 687,047 shares of Common Stock upon payment of an aggregate exercise price of $174,417 ($0.2539 per share), subject to further adjustment under the warrant's antidilution provisions.
- This warrant is exercisable for such number of shares as equals 2.96% of the fully diluted outstanding shares of Common Stock upon payment of an aggregate exercise price of $855,555, and previously was reported as relating to 2,372,503 shares. After giving effect to the warrant's antidilution provisions, as of April 3, 2015, the warrant is exercisable for a total of 2,794,256 shares of Common Stock upon payment of an aggregate exercise price of $855,555 ($0.3062 per share), subject to further adjustment under the warrant's antidilution provisions.
- This warrant is exercisable for such number of shares as equals 1.2129% of the fully diluted outstanding shares of Common Stock upon payment of an aggregate exercise price of $339,206, and previously was reported as relating to 972,165 shares. After giving effect to the warrant's antidilution provisions, as of April 3, 2015, the warrant is exercisable for a total of 1,144,984 shares of Common Stock upon payment of an aggregate exercise price of $339,206 ($0.2963 per share), subject to further adjustment under the warrant's antidilution provisions.